The World Health Organization Tuesday granted emergency use authorization for the second mpox vaccine. The LC16m8 vaccine from Japan's KM Biologics is the second since WHO declared mpox a health emergency in August.

The Mpox outbreak continues to represent a public health emergency, the World Health Organization said on Friday. The WHO first declared the emergency in August, when an outbreak of a new form of mpox spread from the badly-hit Democratic Republic of Congo to neighbouring countries.

The World Health Organization (WHO) says it will keep its alert for mpox at the highest level amid a surge in cases. A WHO committee made up of about a dozen independent experts made the decision at a meeting in Geneva on Friday,

The Mpox outbreak continues to represent a public health emergency, the World Health Organization said on Friday, November 22, 2024. The WHO first declared the emergency in August, when an outbreak of a new form of mpox spread from the badly-hit Democratic Republic of Congo to neighbouring countries.

The World Health Organization said Friday it had decided to keep its alert for the mpox epidemic at the highest level, as the number of cases and countries affected rises.

Following a meeting today of the World Health Organization (WHO) mpox emergency committee, the head of the WHO accepted the group’s recommendation that the outbreaks still warrant a public health emergency of international concern (PHEIC) under the International Health Regulations.

The vaccine is the second to be approved by the UN agency and the first approved for children aged one and older. View on euronews